07/06/2024  16:31:01 Var. +21.50 Volume Denaro17:22:50 Lettera17:22:50 Capitalizzazione di mercato Dividend Y. Rapporto P/E
787.50EUR +2.81% 11
Fatturato: 8,484.80
784.90Quantità in denaro: 100 785.60Quantità in lettera: 100 742.71 bill.EUR - -

Descrizione business

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
David A. Ricks
Consiglio di amministrazione
Anat Ashkenazi, Eric Dozier, Anat Hakim, Edgardo Hernandez, Patrik Jonsson, Michael B. Mason, Johna L. Norton, Leigh Ann Pusey, Diogo Rau, Daniel M. Skovronsky, Jacob Van Naarden, Alonzo Weems, Anne E. White, Ilya Yuffa
Consiglio di sorveglianza
David A. Ricks, Ralph Alvarez, Katherine Baicker, J. Erik Fyrwald, Mary Lynne Hedley, Jamere Jackson, Kimberly H. Johnson, William G. Kaelin Jr., Juan R. Luciano, Marschall S. Runge, Gabrielle Sulzberger, Karen Walker
 

Dati aziendali

Name: Eli Lilly & Company
Indirizzo: Lilly Corporate Center,Indianapolis, Indiana 46285, USA
Telefono: +1-317-276-2000
Fax: +1-317-277-6579
E-mail: -
Internet: www.lilly.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 69.30%
Data dell'IPO: 09/07/1970

Rapporti con gli investitori

Name: Joe Fletcher
IR telefono: +1-317-296-2884
IR Fax: -
IR e-mail: jfletcher@lilly.com

Company calendar

CW 24 | 10/06/2024 Dividend Payment
CW 32 | 08/08/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 30/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
52.47%
Lilly Endowment, Inc
 
10.80%
Vanguard Group, Inc. (The)
 
7.37%
Blackrock Inc.
 
6.91%
PNC Financial Services Group, Inc.
 
5.47%
State Street Corporation
 
3.50%
FMR, LLC
 
3.37%
Capital World Investors
 
2.91%
Primecap Management Company
 
2.67%
Altri
 
4.53%